Home » Topics » BioWorld Science

BioWorld Science
RSS

GlaxoSmithKline synthesizes new MRGPRX2 antagonists

May 3, 2022

Storm Therapeutics identifies new METTL3 inhibitors

May 3, 2022

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

May 3, 2022

OQL-051 shows prophylactic efficacy in models of chemotherapy-induced diarrhea

May 3, 2022

Bridge Biotherapeutics and Cyrus Therapeutics generate next-generation EGFR degraders

May 2, 2022

BioNova Pharmaceuticals menin inhibitor BNM-1192 shows promise for MLL rearranged leukemias

May 2, 2022

CF-370 shows synergy with amikacin in drug-resistant P. aeruginosa acute pneumonia model

May 2, 2022

Innate immune memory underlies inflammatory comorbidities: study

May 2, 2022

New mucolipin-1 activators identified at Lysoway Therapeutics

May 2, 2022

Curome Biosciences presents new quinone derivatives

May 2, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...